1026482-28-9

Upstream product

• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 129229-78-3 2-phenoxymethyl-5-nitrobenzoic acid 
• 2087-41-4 glycyl glycine ethyl ester hydrochloride 

Downstream Products

• 208587-14-8 {(S)-5-Benzyloxycarbonylamino-6-[(S)-2-(3-{[(hydrazinocarbonylmethyl-carbamoyl)-methyl]-carbamoyl}-4-phenoxymethyl-phenylcarbamoyl)-pyrrolidin-1-yl]-6-oxo-hexyl}-carbamic acid tert-butyl ester 
• 1027508-26-4 [2-(5-{[(S)-1-((S)-2-Benzyloxycarbonylamino-6-tert-butoxycarbonylamino-hexanoyl)-pyrrolidine-2-carbonyl]-amino}-2-phenoxymethyl-benzoylamino)-acetylamino]-acetic acid ethyl ester 
• 208587-15-9 ((4S,10S)-3,9,16,19,22-Pentaoxo-24-phenoxymethyl-2,8,15,18,21-pentaaza-tricyclo[21.3.1.0^4,8]heptacosa-1⁽²⁷⁾,23,25-trien-10-yl)-carbamic acid benzyl ester 

Relevant academic research and scientific papers

Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26

The dipeptidyl peptidase IV (DPP IV) activity of CD26 is Characterized by its post-prolinecleaving capacity that plays an important but not yet understood role in biological processes. Here we describe a new family of specific and irreversible inhibitors